Statistics for Cue Biopharma (id:5523 CUE)

Valuation metrics

Market cap

64.62M

Enterprise value

41.79M

Trailing P/E (ttm)

-0.92

Forward P/E

-1.76

PEG ratio

-1.76

Price/Sales (ttm)

7.79

Price/Book (mrq)

1.30

Enterprise Value/Revenue

5.04

Enterprise Value/EBITDA

-0.88

Overview

Shares outstanding

63.35M

Float

48.24M

Shares short

1.78M

% Held by insiders

0.01%

% Held by institutions

0.24%

Average volume (10 days)

724.85K

Average volume (90 days)

Price summary

52-Week low

0.45

52-Week high

3.25

52-Week change

-139.22%

Beta

1.80

50-Day moving average

1.18

200-Day moving average

1.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-390.63%

Operational effectiveness

Return on assets

-52.11%

Return on equity

-138.87%

Income statement

Revenue (ttm)

0.17

Revenue per share (ttm)

0.17

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-47,706,000.00

Net income to common (ttm)

-46,957,000.00

Diluted EPS (ttm)

-0.91

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

30.03M

Total cash per share (mrq)

0.62

Total debt (mrq)

11.26M

Total Debt/Equity (mrq)

52.09

Current ratio (mrq)

206.00%

Book value per share (mrq)

0.78

Cash flow

Cash flow statement

-38,531,000.00

Levered free cash flow (LFCF)

-19,995,250.00